In a regulatory filing, Integra LifeSciences disclosed that its director Barbara Hill bought 36.4K shares of common stock on May 21st in a total transaction size of $996K. Shares of Integra LifeSciences are up 3% at $28.91 after-hours.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IART:
- Integra LifeSciences: Expansion, Audits, and Share Repurchase Plan
- Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
- Target upgraded, CVS downgraded: Wall Street’s top analyst calls
- Integra LifeSciences price target lowered to $25 from $37 at Truist
- Integra LifeSciences price target lowered to $24 from $37 at Morgan Stanley